百川暢銀(300614.SZ):公司會盡量去申請CCER項目
格隆匯6月30日丨有投資者向百川暢銀(300614.SZ)提問:如何測算貴司未來碳匯的收入規模?
百川暢銀回覆:首先,公司有部分項目申請了CDM項目、VCS和GS項目等,這些在國際上已經開發並申請簽發過減排量的項目是無法在國內上再申請CCER的,CCER的減排量最快的就是已經註冊的14個CCER項目抓緊簽發。其次,公司還有大約七八十個項目尚未開發任何減排項目,新的CCER政策出台之後,如果符合政策要求,公司會盡量去申請CCER項目,但是管理辦法出台之後,可能會對存量項目可用於履約的減排量的計算有時間點的劃分問題,所以計算公司碳匯收入多少主要還要看政策的制定,減排量存在一定的不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.